embecta to Participate in Investor Events

Rhea-AI Summary

embecta (Nasdaq: EMBC) announced management will participate in several June 2026 healthcare investor events in the U.S.

These include conferences hosted by Jefferies, TD Cowen, Goldman Sachs, and Truist Securities, featuring one-on-one investor meetings and a fireside session across New York, New Orleans, Miami, and Boston.

Argus Jun 2 session

+6.08% close to close Open Argus

Details

News Market Reaction – EMBC

On Jun 2, the first trading day after this news, EMBC closed 6.08% above the previous close.

Data tracked by StockTitan Argus for the Jun 2 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:

2026 Jefferies Global Healthcare Conference

• Management will host one-on-one investor meetings on Wednesday, June 3, 2026, at the Marriott Marquis, New York City.
  

TD Cowen Diabetes Tech Summit

• Management will host a fireside session on Friday, June 5, 2026, at 9:40 a.m. CT / 10:40 a.m. ET, at the Westin New Orleans, LA.
  

2026 Goldman Sachs 47th Annual Global Healthcare Conference

• Management will host one-on-one investor meetings on Tuesday, June 9, 2026, at the Loews Miami Beach Hotel, Miami, FL.
  

2026 Truist Securities MedTech Conference

• Management will host one-on-one investor meetings on Tuesday, June 16, 2026, at the Boston Harbor Hotel, MA.
  

About embecta 

embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,500 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.

Contacts:

Media	Investors
Christian Glazar	Pravesh Khandelwal
Sr. Director, Corporate Communications	VP, Head of Investor Relations
908-821-6922	551-264-6547
Contact Media Relations	Contact IR

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What investor conferences will embecta (Nasdaq: EMBC) attend in June 2026?

embecta will attend four U.S. healthcare investor conferences in June 2026. According to embecta, management will participate in events hosted by Jefferies, TD Cowen, Goldman Sachs, and Truist Securities, focusing on meetings and discussions with institutional investors across major U.S. cities.

When and where is embecta presenting at the 2026 Jefferies Global Healthcare Conference?

embecta management will hold one-on-one investor meetings on June 3, 2026 in New York City. According to embecta, the meetings take place at the Marriott Marquis, giving investors an opportunity for direct discussions with leadership about the company’s diabetes and medical supplies business.

What is embecta’s schedule at the TD Cowen Diabetes Tech Summit 2026?

embecta will host a fireside session on June 5, 2026 at 9:40 a.m. CT. According to embecta, the session occurs at the Westin New Orleans, offering investors insight into the company’s diabetes technology and insulin delivery focus within the broader medical supplies market.

How is embecta involved in the 2026 Goldman Sachs Global Healthcare Conference?

embecta management will conduct one-on-one investor meetings on June 9, 2026 in Miami. According to embecta, these meetings at the Loews Miami Beach Hotel provide institutional investors time to discuss the company’s strategy and long-term plans in diabetes care and medical supplies.

What will embecta do at the 2026 Truist Securities MedTech Conference?

embecta management will host one-on-one investor meetings on June 16, 2026 in Boston. According to embecta, the meetings at the Boston Harbor Hotel are designed to engage investors on business performance, portfolio evolution, and embecta’s goal of becoming a broad-based medical supplies company.